Therapeutic Immunomodulation in Cardiovascular Disease: Anti-inflammatory Strategies and Landmark Trials
Muhammad Awais, Mohanad Baroudi, Muhammad Hasnain Mankani, Aizaz Ali, Mehnaz Ejaz Khokhar, Nauman Shaukat, Safee Ullah Haider, Absar Ahmed Zafar, Leonardo A Marquez Roa · 2025
Read Therapeutic Immunomodulation in Cardiovascular Disease: Anti-inflammatory Strategies and Landmark Trials by Muhammad Awais, Mohanad Baroudi, Muhammad Hasnain Mankani, Aizaz Ali, Mehnaz Ejaz Khokhar, Nauman Shaukat, Safee Ullah Haider, Absar Ahmed Zafar, Leonardo A Marquez Roa (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12822520.txt.
Description
Muhammad Awais and eight co-authors review the growing use of immune-tuning treatments in heart and vessel disease. Their review was published in twenty twenty-five. Heart disease is the world's top killer, and inflammation plus immune disorder now stand beside classic risk factors as drivers.
Cancer-born tools such as checkpoint inhibitors and engineered T cells are being weighed for heart use, while their own heart harms need watching. The review traces how cytokine signals, autoimmunity, and vessel injury set both benefit and toxicity. It also covers landmark trials of anti-inflammatory drugs, including interleukin blockers. The field where immunology meets cardiology is young but moving fast. The authors map its promise and its safety traps.
Catalog record
| CREATOR | Muhammad Awais, Mohanad Baroudi, Muhammad Hasnain Mankani, Aizaz Ali, Mehnaz Ejaz Khokhar, Nauman Shaukat, Safee Ullah Haider, Absar Ahmed Zafar, Leonardo A Marquez Roa |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |